Cygnal Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cygnal Therapeutics's estimated annual revenue is currently $1.2M per year.
- Cygnal Therapeutics's estimated revenue per employee is $77,500
- Cygnal Therapeutics's total funding is $65M.
Employee Data
- Cygnal Therapeutics has 16 Employees.
- Cygnal Therapeutics grew their employee count by -11% last year.
Cygnal Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Cygnal Therapeutics?
Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by our dynamic Exoneural Medicine Platformￃﾢ￢ﾀﾞￂﾢ, we are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.
keywords:N/A
$65M
Total Funding
16
Number of Employees
$1.2M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cygnal Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Research Associate | Reveal Email/Phone |
2 | Senior Scientist, immuno-oncology | Reveal Email/Phone |
3 | SVP, IP & Legal Affairs | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
5 | Research Assistant | Reveal Email/Phone |
6 | Research Assistant | Reveal Email/Phone |
7 | Scientist | Reveal Email/Phone |
8 | Senior Research Associate | Reveal Email/Phone |
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 16 | -6% | N/A |
#2 | $2.5M | 16 | 7% | N/A |
#3 | $1.2M | 16 | -6% | $59M |
#4 | $1.9M | 16 | 0% | N/A |
#5 | $1.7M | 16 | 7% | N/A |